RECURRENT
Clinical trials for RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECURRENT trials appear
Sign up with your email to follow new studies for RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new combination of two existing drugs, lorlatinib and ramucirumab, for people with advanced lung cancer that has a specific genetic change called ALK. The main goals are to find the safest dose of the drug combination and to see how well it works at contro…
Matched conditions: RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New 'Living Drug' tested for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis early-stage study is testing a new type of treatment called CAR-T cell therapy for women with ovarian cancer that has returned and is resistant to standard platinum-based chemotherapy. Doctors will collect a patient's own immune cells, modify them in a lab to better target t…
Matched conditions: RECURRENT
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat head and neck cancers
Disease control Recruiting nowThis study is testing a new, experimental treatment called CAR-T cell therapy for people with head and neck cancer that has come back or stopped responding to standard treatments. The main goals are to find a safe dose and see what side effects occur. Researchers will collect a p…
Matched conditions: RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Could exercise keep cancer from coming back?
Knowledge-focused Recruiting nowThis study looks at whether exercise after cancer treatment affects how long survivors stay cancer-free and their overall survival. Researchers will analyze existing health records from 1,000 adult cancer survivors who completed treatment at least 3 months ago. The goal is to und…
Matched conditions: RECURRENT
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC
-
Looking back to find a better path forward for cervical cancer
Knowledge-focused Recruiting nowThis study looks back at the medical records of about 350 people whose cervical cancer returned or spread to a few new sites. Researchers want to understand which combinations of treatments—like chemotherapy, radiation, or surgery—led to the best survival and quality of life. The…
Matched conditions: RECURRENT
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated Mar 03, 2026 14:06 UTC